Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Soraya Berjaya Indonesia Tbk. (SPRE) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Soraya Berjaya Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Soraya Berjaya Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Soraya Berjaya Indonesia Tbk. trades at Rp86 (market cap 71.2B, 362.9K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 4.4× Soraya Berjaya Indonesia Tbk.'s market cap, and Soraya Berjaya Indonesia Tbk. is more actively traded (362.9K versus 41.7K). Which is the better fit depends on your goals.

DGNSSPRE
Market Cap
316.25B71.2B
Volume
41.7K362.9K
Lot
4173.63K
Turnover
9.66M31.27M
Average Price
231.6586.16
Value
9.66M31.27M
Indicative Equilibrium Price
23086
Indicative Equilibrium Volume
2.4K324

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
SPRE
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Soraya Berjaya Indonesia Tbk.

PT. Soraya Berjaya Indonesia (Company) was established based on Deed No. 05 dated March 05, 2015 by Notary Martalena, S.H., in Padang. Perseroan memulai kegiatan komersilnya pada tahun 2015. dengan mengoperasikan menggunakan merek dagang Soraya Bed Sheet.

Read more on SPRE